Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis

Launched by SOHAG UNIVERSITY · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new test called the GeneXpert, which is used to detect tuberculosis (TB), a serious infection that affects the lungs. The researchers want to see how well the GeneXpert works compared to the usual methods for diagnosing TB, like looking at samples under a microscope or growing bacteria in a lab. They are particularly interested in how the GeneXpert can detect TB in patients whose initial tests come back negative.

To participate in this trial, you need to be someone who is suspected of having tuberculosis, but it’s important to note that children and people who have already been diagnosed with TB cannot join. The trial is not currently recruiting participants, but once it starts, those who qualify will have the chance to help researchers find the best ways to diagnose TB, which could lead to faster and more accurate tests in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All suspected tuberculous patients.
• Exclusion Criteria:
• • children
• • Previously diagnosed patients.